CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: Tracking the FDA expert review of Replimune’s melanoma treatment

AdComRP1Neutral
AI Analysis

Summary

The FDA is holding an expert panel review meeting for Replimune's experimental melanoma treatment RP1. The outcome and timing details of the review are not specified in this brief announcement.

Importance:7/10
Sentiment:
0.00
FDA advisory committeemelanomaimmunotherapy

Read the original article

Published by STAT News on July 30, 2026 10:00 AM

Read Original